Zepbound - Tirzepatide for obesity approval
Podcast: Docs Who LiftPublished On: Fri Nov 10 2023
Description: Drs. Karl and Spencer discuss how tirzepatide is now approved for obesity. Learn: When will it be available How much will is cost Any differences compared to Mounjaro Surmount 3 trial Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
The note was deleted
The note was saved
Your message was sent